Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified release formulations of memantine oral dosage forms

Modified release formulations of memantine oral dosage forms

US Patent 10660868 · Granted May 26, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations, methods, kits, and dosage forms for treating atopic dermatitis and2024
Pharmaceutical formulations containing dopamine receptor ligands2022
Pharmaceutical formulations containing dopamine receptor ligands2022
Stable formulations of linaclotide2020
Formulations, methods, kit, and dosage forms for improved stability of an active2020
Stable formulations of linaclotide2020
Pharmaceutical formulations containing dopamine receptor ligands2019
Pharmaceutical formulations containing dopamine receptor ligands2019
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphoox2017
Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-c2017
Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphoox2016
Crystalline forms of (1S,2R)-2-(amino methyl)-N,N-diethyl-1-phenyl cyclopropane 2016